(IR) Ingersoll Rand - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US45687V1061

AirCompressors, Pumps, PowerTools, VacuumSystems, FluidTransferEquipment

IR EPS (Earnings per Share)

EPS (Earnings per Share) of IR over the last years for every Quarter: "2020-09": 0.4, "2020-12": 0.53, "2021-03": 0.45, "2021-06": 0.46, "2021-09": 0.57, "2021-12": 0.68, "2022-03": 0.49, "2022-06": 0.54, "2022-09": 0.62, "2022-12": 0.72, "2023-03": 0.65, "2023-06": 0.68, "2023-09": 0.77, "2023-12": 0.86, "2024-03": 0.78, "2024-06": 0.83, "2024-09": 0.84, "2024-12": 0.84, "2025-03": 0.72, "2025-06": 0.8, "2025-09": 0,

IR Revenue

Revenue of IR over the last years for every Quarter: 2020-09: 1112.5, 2020-12: 1510.7, 2021-03: 1129.5, 2021-06: 1279.1, 2021-09: 1325, 2021-12: 1418.8, 2022-03: 1337, 2022-06: 1439.9, 2022-09: 1515.7, 2022-12: 1623.7, 2023-03: 1629.3, 2023-06: 1686.5, 2023-09: 1738.9, 2023-12: 1821.4, 2024-03: 1670.1, 2024-06: 1805.3, 2024-09: 1861, 2024-12: 1898.6, 2025-03: 1716.8, 2025-06: 1887.9, 2025-09: null,

Description: IR Ingersoll Rand

Ingersoll Rand Inc. is a global provider of mission-critical technologies and services, operating in two main segments: Industrial Technologies and Services, and Precision and Science Technologies. The company offers a diverse range of products, including air and gas compression, vacuum, and blower products, as well as precision dosing and liquid handling systems, serving various industries such as industrial manufacturing, medical, and energy.

From a business perspective, Ingersoll Rands revenue streams are diversified across multiple brands and geographies, reducing dependence on any single market or product. The companys Industrial Technologies and Services segment is likely driven by demand for industrial equipment and aftermarket services, while the Precision and Science Technologies segment is driven by demand for precision engineering solutions in various high-growth industries. Key performance indicators (KPIs) to watch include revenue growth, segment margins, and return on invested capital (ROIC).

To further analyze Ingersoll Rands performance, we can examine additional KPIs such as debt-to-equity ratio, interest coverage ratio, and operating cash flow margin. A debt-to-equity ratio of around 0.6x and an interest coverage ratio of 4x suggest a relatively healthy balance sheet. Operating cash flow margin, which is likely in the range of 15-20%, indicates a strong ability to generate cash from operations. Furthermore, Ingersoll Rands commitment to innovation is reflected in its research and development (R&D) expenses, which are likely a significant percentage of revenue.

Ingersoll Rands competitive position is strengthened by its diversified product portfolio, global reach, and strong brand recognition. The companys ability to innovate and expand its product offerings in high-growth areas such as medical and life sciences technologies will be crucial in driving long-term growth. As a Trading Analyst, its essential to monitor Ingersoll Rands financial performance, industry trends, and competitive landscape to identify potential trading opportunities.

IR Stock Overview

Market Cap in USD 31,192m
Sub-Industry Industrial Machinery & Supplies & Components
IPO / Inception 2017-05-12

IR Stock Ratings

Growth Rating 22.1%
Fundamental 54.7%
Dividend Rating 5.09%
Return 12m vs S&P 500 -34.3%
Analyst Rating 3.94 of 5

IR Dividends

Dividend Yield 12m 0.11%
Yield on Cost 5y 0.22%
Annual Growth 5y -47.59%
Payout Consistency 82.4%
Payout Ratio 2.5%

IR Growth Ratios

Growth Correlation 3m -17.4%
Growth Correlation 12m -71.3%
Growth Correlation 5y 85.9%
CAGR 5y 19.37%
CAGR/Max DD 3y (Calmar Ratio) 0.53
CAGR/Mean DD 3y (Pain Ratio) 2.34
Sharpe Ratio 12m -1.36
Alpha -43.07
Beta 1.431
Volatility 25.67%
Current Volume 2205.2k
Average Volume 20d 3552.8k
Stop Loss 73.8 (-3%)
Signal -0.75

Piotroski VR‑10 (Strict, 0-10) 6.0

Net Income (522.6m TTM) > 0 and > 6% of Revenue (6% = 441.9m TTM)
FCFTA 0.08 (>2.0%) and ΔFCFTA 0.21pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)
NWC/Revenue 31.99% (prev 29.54%; Δ 2.45pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)
CFO/TA 0.08 (>3.0%) and CFO 1.43b > Net Income 522.6m (YES >=105%, WARN >=100%)
Net Debt (3.54b) to EBITDA (1.65b) ratio: 2.15 <= 3.0 (WARN <= 3.5)
Current Ratio 2.29 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)
Outstanding Shares last Quarter (400.5m) change vs 12m ago -1.69% (target <= -2.0% for YES)
Gross Margin 43.74% (prev 43.49%; Δ 0.24pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)
Asset Turnover 41.03% (prev 39.44%; Δ 1.59pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)
Interest Coverage Ratio 4.64 (EBITDA TTM 1.65b / Interest Expense TTM 249.5m) >= 6 (WARN >= 3)

Altman Z'' 2.07

(A) 0.13 = (Total Current Assets 4.19b - Total Current Liabilities 1.83b) / Total Assets 18.06b
(B) 0.14 = Retained Earnings (Balance) 2.56b / Total Assets 18.06b
(C) 0.06 = EBIT TTM 1.16b / Avg Total Assets 17.95b
(D) 0.31 = Book Value of Equity 2.42b / Total Liabilities 7.90b
Total Rating: 2.07 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 54.66

1. Piotroski 6.0pt = 1.0
2. FCF Yield 3.91% = 1.95
3. FCF Margin 18.44% = 4.61
4. Debt/Equity 0.48 = 2.39
5. Debt/Ebitda 2.15 = -0.29
6. ROIC - WACC (= -7.87)% = -9.84
7. RoE 5.10% = 0.42
8. Rev. Trend 81.77% = 6.13
9. EPS Trend -34.35% = -1.72

What is the price of IR shares?

As of October 14, 2025, the stock is trading at USD 76.10 with a total of 2,205,221 shares traded.
Over the past week, the price has changed by -8.76%, over one month by -3.41%, over three months by -13.15% and over the past year by -25.64%.

Is Ingersoll Rand a good stock to buy?

Neither. Based on ValueRay´s Fundamental Analyses, Ingersoll Rand is currently (October 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 54.66 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of IR is around 73.97 USD . This means that IR is currently overvalued and has a potential downside of -2.8%.

Is IR a buy, sell or hold?

Ingersoll Rand has received a consensus analysts rating of 3.94. Therefore, it is recommended to buy IR.
  • Strong Buy: 7
  • Buy: 2
  • Hold: 8
  • Sell: 0
  • Strong Sell: 0

What are the forecasts/targets for the IR price?

Issuer Target Up/Down from current
Wallstreet Target Price 91.1 19.8%
Analysts Target Price 91.1 19.8%
ValueRay Target Price 83.5 9.7%

Last update: 2025-10-11 03:50

IR Fundamental Data Overview

Market Cap USD = 31.19b (31.19b USD * 1.0 USD.USD)
P/E Trailing = 60.8372
P/E Forward = 22.6244
P/S = 4.2356
P/B = 3.3168
P/EG = 1.149
Beta = 1.431
Revenue TTM = 7.36b USD
EBIT TTM = 1.16b USD
EBITDA TTM = 1.65b USD
Long Term Debt = 4.78b USD (from longTermDebt, last quarter)
Short Term Debt = 65.4m USD (from shortTermDebt, last quarter)
Debt = 4.85b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.54b USD (from netDebt column, last quarter)
Enterprise Value = 34.73b USD (31.19b + Debt 4.85b - CCE 1.31b)
Interest Coverage Ratio = 4.64 (Ebit TTM 1.16b / Interest Expense TTM 249.5m)
FCF Yield = 3.91% (FCF TTM 1.36b / Enterprise Value 34.73b)
FCF Margin = 18.44% (FCF TTM 1.36b / Revenue TTM 7.36b)
Net Margin = 7.10% (Net Income TTM 522.6m / Revenue TTM 7.36b)
Gross Margin = 43.74% ((Revenue TTM 7.36b - Cost of Revenue TTM 4.14b) / Revenue TTM)
Gross Margin QoQ = 43.69% (prev 44.59%)
Tobins Q-Ratio = 1.92 (Enterprise Value 34.73b / Total Assets 18.06b)
Interest Expense / Debt = 1.29% (Interest Expense 62.7m / Debt 4.85b)
Taxrate = 74.73% (21.0m / 28.1m)
NOPAT = 292.5m (EBIT 1.16b * (1 - 74.73%))
Current Ratio = 2.29 (Total Current Assets 4.19b / Total Current Liabilities 1.83b)
Debt / Equity = 0.48 (Debt 4.85b / totalStockholderEquity, last quarter 10.09b)
Debt / EBITDA = 2.15 (Net Debt 3.54b / EBITDA 1.65b)
Debt / FCF = 2.60 (Net Debt 3.54b / FCF TTM 1.36b)
Total Stockholder Equity = 10.25b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.89% (Net Income 522.6m / Total Assets 18.06b)
RoE = 5.10% (Net Income TTM 522.6m / Total Stockholder Equity 10.25b)
RoCE = 7.70% (EBIT 1.16b / Capital Employed (Equity 10.25b + L.T.Debt 4.78b))
RoIC = 1.95% (NOPAT 292.5m / Invested Capital 15.03b)
WACC = 9.82% (E(31.19b)/V(36.04b) * Re(11.29%) + D(4.85b)/V(36.04b) * Rd(1.29%) * (1-Tc(0.75)))
Discount Rate = 11.29% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.95%
[DCF Debug] Terminal Value 71.62% ; FCFE base≈1.34b ; Y1≈1.65b ; Y5≈2.81b
Fair Price DCF = 71.89 (DCF Value 28.57b / Shares Outstanding 397.5m; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: -34.35 | EPS CAGR: -57.16% | SUE: -4.0 | # QB: 0
Revenue Correlation: 81.77 | Revenue CAGR: 8.31% | SUE: 1.42 | # QB: 1

Additional Sources for IR Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle